Drug Shortage Report for LAMICTAL
| Report ID |
20136 |
| Drug Identification Number |
02142112 |
| Brand name |
LAMICTAL |
| Common or Proper name |
Lamotrigine tablets |
| Company Name |
GLAXOSMITHKLINE INC |
| Market Status |
MARKETED |
| Active Ingredient(s) |
LAMOTRIGINE |
| Strength(s) |
150MG |
| Dosage form(s) |
TABLET |
| Route of administration |
ORAL |
| Packaging size |
60's |
| ATC code |
N03AX |
| ATC description |
ANTIEPILEPTICS |
| Reason for shortage |
Shortage of an active ingredient. |
| Anticipated start date |
|
| Actual start date |
2017-10-26 |
| Estimated end date |
2018-03-20 |
| Actual end date |
2018-03-15 |
| Shortage status |
Resolved |
| Updated date |
2018-03-16 |
| Company comments |
|
| Health Canada comments |
|
| Tier 3 Status |
No |
| Company contact information |
1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other
versions.
